Document is current
Any future updates will be listed below
-
Authors
Steflik, Heidi J. https://orcid.org/0000-0003-2168-4926
Charlton, Jennifer R.
Briley, Meagan
Selewski, David T.
Gist, Katja M.
Hanna, Mina H. https://orcid.org/0000-0002-8343-9494
Askenazi, David
Griffin, Russell
,
Sarkar, Subrata
Kent, Alison
Fletcher, Jeffery
Abitbol, Carolyn L.
DeFreitas, Marissa
Duara, Shahnaz
Swanson, Jonathan R.
Guillet, Ronnie
D’Angio, Carl
Mian, Ayesa
Rademacher, Erin
Mhanna, Maroun J.
Raina, Rupesh
Kumar, Deepak
Ambalavanan, Namasivayam
Arikan, Ayse Akcan
Rhee, Christopher J.
Goldstein, Stuart L.
Nathan, Amy T.
Kupferman, Juan C.
Bhutada, Alok
Rastogi, Shantanu
Bonachea, Elizabeth
Ingraham, Susan
Mahan, John
Nada, Arwa
Jetton, Jennifer
Brophy, Patrick D.
Colaizy, Tarah T.
Klein, Jonathan M.
Cole, F. Sessions
Davis, T. Keefe
Dower, Joshua
Milner, Lawrence
Smith, Alexandra
Fuloria, Mamta
Reidy, Kimberly
Kaskel, Frederick J.
Soranno, Danielle E.
Gien, Jason
Chishti, Aftab S.
Hingorani, Sangeeta
Juul, Sandra
Starr, Michelle
Wong, Craig S.
Joseph, Catherine
DuPont, Tara
Ohls, Robin
Staples, Amy
Rohatgi, Smriti
Sethi, Sidharth K.
Wazir, Sanjay
Khokhar, Surender
Perazzo, Sofia
Ray, Patricio E.
Revenis, Mary
Mammen, Cherry
Synnes, Anne
Wintermark, Pia
Zappitelli, Michael
Woroniecki, Robert
Sridhar, Shanthy
-
Funding
Funding for this research was provided by:
100 Women Charitable Foundation
University of Alabama at Birmingham (UL1TR001417)
- License Information
-
More Information
Article History
Received: 30 January 2023
Revised: 6 April 2023
Accepted: 14 April 2023
First Online: 26 April 2023
Competing interests
: All authors report no real or perceived conflicts of interest that could affect the study design, collection, analysis, and interpretation of data, the writing of the report, or the decision to submit the manuscript for publication. For full disclosure, we provide the additional list of authors’ other funding sources that are not directly related to this study. DJA is a consultant for Baxter, Nuwellis, Bioporto, and Seastar. His institution receives grant funding for education and research that is not related to this project from NIH, Baxter, Nuwellis, Medtronic, Bioporto, Portero, and Seastar. He has patents pending on inventions to improve the kidney care of neonates. He is the Founder and Chief Scientific Officer for Zorro-Flow Inc. HJS received research grants with Baxter. No other disclosures were reported. KG is a consultant for Bioporto and Potrero Medical. JRC is on the Executive Board for the Neonatal Kidney Collaborative, a consultant for Medtronics, and an investor in Zorro-Flow.
